HomeMarkets Markets Crispr Whipsaws As Wall Street Eyes Its Possible Gene-Editing Blockbuster By news February 22, 2024 0 150 FacebookTwitterPinterestWhatsApp Crispr Therapeutics (CRSP) reported its first profit in 10 quarters on Wednesday, and CRSP stock whipsawed. This is the company’s first earnings …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected156,727FansLike396,312FollowersFollow2,310SubscribersSubscribe Latest Articles AI The Global Semiconductor Industry: China’s Challenges, Shifting Dynamics and Companies That May Benefit AI AMD deprioritizing flagship gaming GPUs: Jack Hyunh talks new strategy against Nvidia in gaming market Markets China’s probe of Canadian canola will put both exports and farmers in jeopardy Hot Items China Will Soon Lose the Title of “World’s Manufacturer” Markets DOJ: Russia Aimed Propaganda at Gamers, Minorities to Swing 2024 Election Load more